Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Expro Holdings NV (NYSE: XPRO) reported first quarter EPS of $0.250, $0.13 better than the analyst estimate of $0.120. Revenue for the quarter came in at $391M versus the consensus estimate of $370.92M.
Guidance
Expro Holdings NV sees Q2 2025 revenue of $400.000M-$410.000M versus the analyst consensus of $430.400M.
Expro Holdings NV’s stock price closed at $8.04. It is down -36.340% in the last 3 months and down -57.620% in the last 12 months.
Expro Holdings NV saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Expro Holdings NV’s stock price’s past reactions to earnings here.
According to InvestingPro, Expro Holdings NV’s Financial Health score is "good performance".
Check out Expro Holdings NV’s recent earnings performance, and Expro Holdings NV’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar